One of the most typical hallmarks of prostate cancer cells is their exquisite dependence on androgens, which is the basis of the widely applied androgen deprivation therapy. Among the variety of key cellular processes and functions that are regulated by androgens, lipid metabolism stands out by its complex regulation and its many intricate links with cancer cell biology. Here, we review our current knowledge on the links between androgens and lipid metabolism in prostate cancer, and highlight recent developments and insights into the links between key oncogenic stimuli and altered lipid synthesis and/or uptake that may hold significant potential for biomarker development and provide new vulnerabilities for therapeutic intervention.Lisa M Bu...
The androgen receptor (AR) is the key oncogenic driver of prostate cancer, and despite implementatio...
Dysregulated lipid metabolism is a prominent feature of prostate cancer that is driven by androgen r...
Prostate cancer (PCa) remains one of the deadliest cancers globally and is primarily driven by aberr...
De novo lipogenesis is a well-described androgen receptor (AR)–regulated metabolic pathway that supp...
De novo lipogenesis is a well-described androgen receptor (AR)-regulated metabolic pathway that supp...
Prostate cancer (PCa) is the most common cancer in men, and more than 10% of men will be diagnosed w...
AbstractZeyad D Nassar, Margaret M Centenera, Jelle Machiels, Samuel J Polacek, Katarzyna Bloch, Way...
Prostate cancer (PCa) is the second leading cause of cancer-related death in the US. Androgen recept...
Cancer is increasingly recognized as an extraordinarily heterogeneous disease featuring an intricate...
873-878The reprogramming of lipid metabolism and signaling pathways is the central aspect of cancer ...
Metabolic dysregulation is regarded as an important driver in cancer development and progression. Th...
Prostate cancer (PCa) is the most commonly diagnosed cancer among men and is the second leading caus...
Prostate cancer (PCa) is the most frequently diagnosed male cancer in Australia and a leading cause ...
Recent evidence associates prostate cancer with high cholesterol levels, with cholesterol being an i...
Recent evidence associates prostate cancer with high cholesterol levels, with cholesterol being an i...
The androgen receptor (AR) is the key oncogenic driver of prostate cancer, and despite implementatio...
Dysregulated lipid metabolism is a prominent feature of prostate cancer that is driven by androgen r...
Prostate cancer (PCa) remains one of the deadliest cancers globally and is primarily driven by aberr...
De novo lipogenesis is a well-described androgen receptor (AR)–regulated metabolic pathway that supp...
De novo lipogenesis is a well-described androgen receptor (AR)-regulated metabolic pathway that supp...
Prostate cancer (PCa) is the most common cancer in men, and more than 10% of men will be diagnosed w...
AbstractZeyad D Nassar, Margaret M Centenera, Jelle Machiels, Samuel J Polacek, Katarzyna Bloch, Way...
Prostate cancer (PCa) is the second leading cause of cancer-related death in the US. Androgen recept...
Cancer is increasingly recognized as an extraordinarily heterogeneous disease featuring an intricate...
873-878The reprogramming of lipid metabolism and signaling pathways is the central aspect of cancer ...
Metabolic dysregulation is regarded as an important driver in cancer development and progression. Th...
Prostate cancer (PCa) is the most commonly diagnosed cancer among men and is the second leading caus...
Prostate cancer (PCa) is the most frequently diagnosed male cancer in Australia and a leading cause ...
Recent evidence associates prostate cancer with high cholesterol levels, with cholesterol being an i...
Recent evidence associates prostate cancer with high cholesterol levels, with cholesterol being an i...
The androgen receptor (AR) is the key oncogenic driver of prostate cancer, and despite implementatio...
Dysregulated lipid metabolism is a prominent feature of prostate cancer that is driven by androgen r...
Prostate cancer (PCa) remains one of the deadliest cancers globally and is primarily driven by aberr...